omeprazole
CLINICAL USE
Gastric acid suppression
DOSE IN NORMAL RENAL FUNCTION
Oral: 10–120 mg daily IV: 40 mg once daily for up to 5 days Patients with recent bleeding on endoscopy: 80 mg stat followed by 8 mg/hour for 72 hours (British Society of Gastroenterology)
PHARMACOKINETICS
Molecular weight                           :345.4 %Protein binding                           :95 %Excreted unchanged in urine     : Minimal Volume of distribution (L/kg)       :0.3half-life – normal/ESRD (hrs)      :0.5–3/Unchanged DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in normal renal function HD                     :Not dialysed. Dose as in normal renal function HDF/high flux   :Unknown dialysability. Dose as in normal renal function CAV/VVHD      :Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnticoagulants: effect of coumarins possibly enhancedAnti-epileptics: effects of phenytoin possibly enhancedAntivirals: reduced atazanavir concentration – avoid concomitant use; AUC of saquinavir increased by 82% (increased risk of toxicity)Ciclosporin: variable response; mostly increase in ciclosporin levelCilostazol: increased cilostazol concentration – avoid concomitant use Tacrolimus: may increase tacrolimus concentration ADMINISTRATION
Reconstition
5 mL solvent provided per 40 mg vial Route
Oral, IV Rate of Administration
Bolus: over 5 minutes Infusion: 40 mg over 20–30 minutes Continuous infusion: 8 mg/hour Comments
Add to 100 mL sodium chloride 0.9% or glucose 5%Once diluted stable for 12 hours in sodium chloride 0.9% and 3 hours in glucose 5%Use oral as soon as possible 200 mg in 50 mL for 8 mg/hour infusion. (UK Critical Care Group, Minimum Infusion Volumes for fluid restricted critically ill patients, 3rd Edition, 2006) OTHER INFORMATION
Omeprazole clearance is not limited by renal disease.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home